Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Statistics

Total Valuation

ALNY has a market cap or net worth of $32.44 billion. The enterprise value is $32.49 billion.

Market Cap	32.44B
Enterprise Value	32.49B

Important Dates

The last earnings date was Thursday, February 13, 2025, before market open.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ALNY has 129.46 million shares outstanding. The number of shares has increased by 2.20% in one year.

Current Share Class	129.46M
Shares Outstanding	129.46M
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	96.56%
Float	124.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.23
Forward PS	11.76
PB Ratio	483.55
P/TBV Ratio	483.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.78, with a Debt / Equity ratio of 40.89.

Current Ratio	2.78
Quick Ratio	2.61
Debt / Equity	40.89
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-2.74%
Return on Invested Capital (ROIC)	-4.19%
Return on Capital Employed (ROCE)	-5.79%
Revenue Per Employee	$1.07M
Profits Per Employee	-$132,456
Employee Count	2,100
Asset Turnover	0.56
Inventory Turnover	3.86

Taxes

Income Tax	-99.22M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.41% in the last 52 weeks. The beta is 0.35, so ALNY's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+67.41%
50-Day Moving Average	254.77
200-Day Moving Average	242.77
Relative Strength Index (RSI)	39.26
Average Volume (20 Days)	687,178

Short Selling Information

The latest short interest is 2.94 million, so 2.27% of the outstanding shares have been sold short.

Short Interest	2.94M
Short Previous Month	3.15M
Short % of Shares Out	2.27%
Short % of Float	2.36%
Short Ratio (days to cover)	4.37

Income Statement

In the last 12 months, ALNY had revenue of $2.25 billion and -$278.16 million in losses. Loss per share was -$2.18.

Revenue	2.25B
Gross Profit	1.92B
Operating Income	-176.89M
Pretax Income	-61.70M
Net Income	-278.16M
EBITDA	-120.22M
EBIT	-176.89M
Loss Per Share	-$2.18

Balance Sheet

The company has $2.69 billion in cash and $2.74 billion in debt, giving a net cash position of -$48.92 million or -$0.38 per share.

Cash & Cash Equivalents	2.69B
Total Debt	2.74B
Net Cash	-48.92M
Net Cash Per Share	-$0.38
Equity (Book Value)	67.09M
Book Value Per Share	0.52
Working Capital	2.11B

Cash Flow

In the last 12 months, operating cash flow was -$8.31 million and capital expenditures -$34.28 million, giving a free cash flow of -$42.59 million.

Operating Cash Flow	-8.31M
Capital Expenditures	-34.28M
Free Cash Flow	-42.59M
FCF Per Share	-$0.33

Margins

Gross margin is 85.62%, with operating and profit margins of -7.87% and -12.37%.

Gross Margin	85.62%
Operating Margin	-7.87%
Pretax Margin	-16.79%
Profit Margin	-12.37%
EBITDA Margin	-5.35%
EBIT Margin	-7.87%
FCF Margin	n/a

Dividends & Yields

ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	-2.20%
Earnings Yield	-0.86%
FCF Yield	-0.13%

Analyst Forecast

The average price target for ALNY is $305.86, which is 22.06% higher than the current price. The consensus rating is "Buy".

Price Target	$305.86
Price Target Difference	22.06%
Analyst Consensus	Buy
Analyst Count	23
Revenue Growth Forecast (5Y)	24.30%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALNY has an Altman Z-Score of 2.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	3